EDMONTON, June 25 /CNW/ -
What: ANOTHER EDMONTON FIRST: CAPITAL HEALTH, THE UNIVERSITY OF ALBERTA
AND THE NORTHERN ALBERTA CLINICAL TRIALS AND RESEARCH CENTRE (NACTRC)
LAUNCH ALBERTA'S FIRST PHASE 1 CLINICAL TRIALS UNIT.
When: Tuesday, June 26, 2007, 11 a.m. - noon.
Where: McMullen Gallery, Walter Mackenzie Health Sciences Centre, U of A
- Dr. Richard Fedorak (Director, NACTRC)
- Mayor Stephen Mandel
- Sheila Weatherill (President and CEO, Capital Health)
- Dr. Andrew Greenshaw (Associate Vice-President Research, U of A)
Why: Capital Health, the University of Alberta and the Northern Alberta
Clinical Trials and Research Centre (NACTRC), with support from Edmonton
Economic Development Corporation and the Province of Alberta, will
officially launch the University of Alberta Hospital's Phase 1 clinical
trials facility, the first of its kind in Alberta, and one of only four
in Canada. The Phase 1 Unit will facilitate first-in-human testing of new
molecules for medical treatment, and will be a Canadian and world leader
in Phase 1 trials for local biotech firms and global pharmaceutical
companies alike. This launch follows up on the joint pledge by NACTRC,
CH, the U of A and the EEDC to increase research investment in Edmonton
from $10 million to $75 million a year in the next five years.
All media are welcome.
For further information:
For further information: contact Scott Lingley at Donovan Creative
Communications: firstname.lastname@example.org, (780) 428-0411